A
$ Value
$0
Shares
80,000
Price
$0
Filed
Jun 9
Insider
Name
REICIN ALISE
Title
—
CIK
0001757533
Roles
Director
Transaction Details
Transaction Date
2025-06-05
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
80,000
Footnotes
The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 5, 2026 and (ii) immediately prior to the 2026 annual meeting of stockholders of Sana Biotechnology, Inc. ("Sana"), provided that the reporting person provides continuous service to Sana through such date.
Filing Info
REICIN ALISE's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-04 | TECX | A | $0 |
| 2026-03-04 | TECX | A | $0 |
| 2026-02-11 | TECX | ▲ | $53K ★ |
| 2026-02-04 | TECX | F | $95K |
| 2025-12-31 | TECX | M | $26K |
| 2025-12-31 | TECX | M | — |
| 2025-09-25 | TECX | A | $0 |
| 2025-09-25 | TECX | A | $0 |
| 2025-06-20 | TECX | F | $17K |
| 2025-06-05 | SANA | A | $0 |
Other Insiders at SANA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Bishop Hans Edgar | — | — | 2026-04-06 |
|
Wyrick Susan D.
See Remarks
|
— | — | 2026-03-05 |
|
Harr Steve
President & CEO
|
— | — | 2026-03-05 |
|
Piper Brian
EVP, Chief Financial Officer
|
— | — | 2026-02-17 |